Dorchester Wealth Management’s Novartis NVS Stock Holding History

Dorchester Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,845	Closed	-$327K	–	162
2024 Q3	$327K	Hold	2,845	–	–	0.06%	122
2024 Q2	$303K	Sell	2,845 -100	-3%	-$10K	0.06%	125
2024 Q1	$285K	Hold	2,945	–	–	0.05%	136
2023 Q4	$297K	Hold	2,945	–	–	0.06%	129
2023 Q3	$300K	Hold	2,945	–	–	0.06%	124
2023 Q2	$297K	Hold	2,945	–	–	0.06%	118
2023 Q1	$271K	Hold	2,945	–	–	0.06%	129
2022 Q4	$267K	Hold	2,945	–	–	0.06%	122
2022 Q3	$224K	Hold	2,945	–	–	0.05%	137
2022 Q2	$249K	Buy	2,945 +345	+13%	+$30.3K	0.05%	135
2022 Q1	$285K	Sell	2,600 -380	-13%	-$32.9K	0.05%	135
2021 Q4	$261K	Hold	2,980	–	–	0.05%	130
2021 Q3	$244K	Sell	2,980 -100	-3%	-$9K	0.06%	125
2021 Q2	$281K	Hold	3,080	–	–	0.06%	133
2021 Q1	$263K	Sell	3,080 -270	-8%	-$24.2K	0.07%	128
2020 Q4	$316K	Hold	3,350	–	–	0.08%	114
2020 Q3	$291K	Sell	3,350 -100	-3%	-$8.66K	0.09%	108
2020 Q2	$301K	Hold	3,450	–	–	0.1%	107
2020 Q1	$284K	Buy	3,450 +250	+8%	+$22.3K	0.11%	93
2019 Q4	$303K	Buy	3,200 +85	+3%	+$7.63K	0.08%	102
2019 Q3	$271K	Hold	3,115	–	–	0.08%	104
2019 Q2	$284K	Buy	3,115 +526	+20%	+$44.5K	0.08%	106
2019 Q1	$223K	Buy	+2,589	New	+$208K	0.07%	114

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Dorchester Wealth Management's NVS Position: Q4 2024 in Review

Dorchester Wealth Management sold out of Novartis (NVS) in Q4 2024, closing a stake of 2,845 shares — an estimated $327K sold.

Dorchester Wealth Management first reported a position in NVS in Q1 2019 and held it in 23 quarters. The position peaked at $327K in Q3 2024. 1,340 funds tracked by Wall St. Rank hold NVS as of Q4 2024.

Dorchester Wealth Management reported no remaining Novartis position as of Q4 2024 after selling out during the quarter.
Dorchester Wealth Management sold 2,845 Novartis shares in Q4 2024, an estimated $327K.
Dorchester Wealth Management first reported a position in Novartis in Q1 2019 and held it in 23 quarters.
Dorchester Wealth Management's Novartis position peaked at $327K in Q3 2024.
1,340 funds tracked by Wall St. Rank held Novartis as of Q4 2024.

Based on Dorchester Wealth Management's 13F filing for Q4 2024, filed 4 Feb 2025.